Latest ownership filings
4
Boundless Bio, Inc.
2 Apr 24
3
Boundless Bio, Inc.
27 Mar 24
4
Acrivon Therapeutics, Inc.
21 Nov 22
3
Acrivon Therapeutics, Inc.
9 Nov 22
SC 13G/A
Aligos Therapeutics, Inc.
4 Feb 22
SC 13G/A
Verve Therapeutics, Inc.
4 Feb 22
4
Nuvalent, Inc.
3 Aug 21
3
Nuvalent, Inc.
28 Jul 21
SC 13G
Verve Therapeutics, Inc.
28 Jun 21
4
Verve Therapeutics, Inc.
22 Jun 21
3
Verve Therapeutics, Inc.
16 Jun 21
4
Edgewise Therapeutics, Inc.
30 Mar 21
3
Edgewise Therapeutics, Inc.
25 Mar 21
4
Olema Pharmaceuticals, Inc.
24 Nov 20
3
Olema Pharmaceuticals, Inc.
18 Nov 20
4
Aligos Therapeutics, Inc.
22 Oct 20
SC 13G
Aligos Therapeutics, Inc.
22 Oct 20
3
Aligos Therapeutics, Inc.
15 Oct 20
4
PMV Pharmaceuticals, Inc.
29 Sep 20
3
PMV Pharmaceuticals, Inc.
24 Sep 20
4
Dyne Therapeutics, Inc.
23 Sep 20
3
Dyne Therapeutics, Inc.
16 Sep 20
4
Kymera Therapeutics, Inc.
27 Aug 20
3
Kymera Therapeutics, Inc.
20 Aug 20
4
Nurix Therapeutics, Inc.
30 Jul 20
3
Nurix Therapeutics, Inc.
23 Jul 20
4
Forma Therapeutics Holdings, Inc.,
25 Jun 20
3
Forma Therapeutics Holdings, Inc.,
18 Jun 20
4
Generation Bio Co.
18 Jun 20
3
Generation Bio Co.
11 Jun 20
4
Black Diamond Therapeutics, Inc.
5 Feb 20
3
Black Diamond Therapeutics, Inc.
29 Jan 20